Ketamine Treatment Goals: First-Consult Questions

At a first ketamine consultation, ask what improvement would realistically look like for your symptoms, how the clinician will measure it, and what the plan is if you do not improve. Ketamine treatment can help some people, especially those with difficult-to-treat depression, but it is not a guaranteed or one-size-fits-all answer. In 2026, traditional ketamine is still generally prescribed off-label for depression and most mental-health uses; esketamine (Spravato) is the FDA-approved option for treatment-resistant depression. This article is educational, not medical advice, so discuss your own goals, health history, and treatment choices with a licensed clinician.

A useful goal is specific enough to notice in daily life: fewer days unable to get out of bed, less intense suicidal thinking, better sleep, returning to work, or being able to participate in therapy. Your first appointment should help you decide whether the provider has a careful way to connect treatment to those outcomes.

Start with the goal behind treatment

Begin by naming the problem you most want help with. “I want to feel better” is understandable, but it gives you and the clinician little to measure. Try asking:

• Which of my symptoms is ketamine most likely to help, based on the evidence and my history?
• Is the main aim short-term symptom relief, longer-term recovery, or support while I engage in other care?
• What changes in my day-to-day functioning would show that treatment is worthwhile?
• What should I not expect ketamine to change on its own?

The evidence is strongest for some forms of depression, particularly treatment-resistant depression, and evidence for other conditions varies in size and certainty. The American Psychiatric Association consensus statement describes ketamine as a treatment with promising antidepressant effects but important unanswered questions about longer-term use, safety, and maintenance. Ask the clinician to explain how closely your condition matches the people studied, rather than assuming a diagnosis label alone predicts your result.

Ask how progress will be measured

Improvement can be real without being complete, and early changes can be uneven. Ask the provider to identify the measures they will use before treatment begins. These may include a validated depression questionnaire, a review of sleep and functioning, your own symptom log, and input from a therapist or prescribing clinician when you agree to coordination.

Questions that bring clarity include:

• Which rating scale or check-in will we use, and how often?
• What would you consider a meaningful improvement for me?
• How will we distinguish a brief lift in symptoms from a durable benefit?
• When will we pause and reassess whether this remains the right plan?

The U.S. Food and Drug Administration (FDA) requires esketamine to be administered under a Risk Evaluation and Mitigation Strategy because of risks including sedation, dissociation, and misuse or abuse; its prescribing information also describes ongoing assessment within a supervised treatment program. Traditional ketamine care is different and often off-label, but asking how your clinician documents benefit and safety is still reasonable.

Clarify the treatment plan around the goal

Your goal cannot be separated from the setting and support around treatment. Ask whether the clinician recommends in-clinic care, at-home telehealth, or another approach, and why that setting fits your symptoms, medical history, transportation, home environment, and available support. Read more about the practical differences in what an in-clinic infusion experience can involve and at-home ketamine care for anxiety.

Ask directly: “What is the full plan before, during, and after each session?” A clear answer should cover screening, monitoring, transportation or supervision expectations where relevant, follow-up, and coordination with the professionals already involved in your care. If you have a therapist, psychiatrist, primary-care clinician, or family support person, ask how the provider can include them with your permission. Continuity matters especially when treatment ends or your needs change; consider these questions about continuity of care.

Ask what happens if the goal is not met

A careful clinician will discuss nonresponse before treatment starts. Ask how many sessions or how much time they generally use before reviewing the plan, what outcomes would prompt a change, and whether they will recommend returning to or strengthening other evidence-based care. You are not failing treatment if the result is partial, short-lived, or absent; the purpose of tracking is to make a grounded next decision.

It can also help to ask about the possibility of benefit fading and what follow-up looks like. Our guide to what happens when ketamine stops working can help you prepare that conversation. For a broader first-visit list, see these questions to ask before ketamine therapy.

A provider should be able to explain costs, expected follow-up, and the boundaries of their role without pressuring you to commit. If an answer feels vague, ask for it in plain language or take time to discuss it with a trusted clinician or family member.